C07K

Technology



back to "C07K" profile

More Results

Showing 1 to 20 of 42257 results

Patent/Pub #TitleFiling DateIssue/Publication DatePatent Owner
RE49773 Hybrid felts of electrospun nanofibersMay 18, 21Jan 02, 24NANOPAREIL, LLC
RE49625 Nanoscale process to generate reagents selective for individual protein variantsApr 10, 20Aug 29, 23Arizona Board of Regents a body corporate of the State of Arizona acting for and on behalf of Arizona State University
RE49495 Binding polypeptides having a mutated scaffoldApr 06, 20Apr 18, 23Affibody AB
RE49435 Glycan-interacting compounds and methods of useJan 29, 20Feb 28, 23SEAGEN INC.
RE49339 Antibodies to the C3D fragment of complement component 3Apr 10, 19Dec 20, 22The Regents of the University of Colorado a Body Corporate; Musc Foundation for Research Development;
RE49280 TGFbeta type II-type III receptor fusionsApr 04, 19Nov 08, 22501 Board of Regents The University of Texas System
RE49251 Depot systems comprising glatiramer or pharmacologically acceptable salt thereofMar 26, 21Oct 18, 22MAPI PHARMA LTD.
RE49192 Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profileMay 30, 19Aug 30, 22INTERNATIONAL—DRUG—DEVELOPMENT BIOTECH
RE49099 Humanized monoclonal antibodies against activated protein c and uses thereofMay 22, 19Jun 07, 22Bayer Healthcare LLC
RE49076 Compositions and methods for treating renal diseaseJul 23, 19May 17, 22Beth Israel Deaconess Medical Center, Inc.
RE49037 Broadly neutralizing antibody and uses thereofDec 24, 19Apr 19, 22International Aids Vaccine Initiative; The Scripps Research Institute; Cornell University;
RE49026 Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereofOct 06, 17Apr 12, 22MEDICAL DIAGNOSTIC LABORATORIES, LLC
RE48959 Humanized antibodies to LIV-1 and use of same to treat cancerJan 04, 18Mar 08, 22SEAGEN INC.
RE48899 Slanted FBG for SRS suppressionApr 25, 19Jan 25, 22nLIGHT, Inc.
RE48890 Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione after stem cell transplantationFeb 22, 19Jan 11, 22Celgene Corporation
RE48863 toxin and methods thereofApr 18, 19Dec 28, 21Wyeth LLC
RE48862 toxin and methods thereofApr 18, 19Dec 28, 21Wyeth LLC
RE48805 Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion proteinFeb 12, 19Nov 02, 21Vision Global Holdings Ltd.
RE48787 Humanised antibodiesApr 09, 19Oct 26, 21UCB Biopharma SRL
RE48751 Immunoconjugates with an intracellularly-cleavable linkageDec 12, 18Sep 28, 21Immunomedics, Inc.

Showing 1 to 20 of 42257 results